Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 22:6:1379272.
doi: 10.3389/ftox.2024.1379272. eCollection 2024.

Abusive use of anabolic androgenic steroids, male sexual dysfunction and infertility: an updated review

Affiliations
Review

Abusive use of anabolic androgenic steroids, male sexual dysfunction and infertility: an updated review

Rafael de Almeida Azevedo et al. Front Toxicol. .

Abstract

The evolving prevalence of anabolic androgenic steroids (AAS) abuse among nonathletes is alarming because of the known harm to an individual's health. Among the adverse effects of AAS abuse, male infertility and sexual dysfunction have been often reported in the literature, but little is known regarding its actual prevalence, possible underpinning mechanisms, and potential treatments either during or post-AAS usage. Thus, the current narrative review summarizes the state-of-art regarding the effects of AAS on male fertility and sexual function. Evidence was gathered from the latest reviews and recent original studies, specifically from prospective cohorts and clinical trials, ultimately resulting in five main topics of discussion. First, AAS usage is briefly characterized by its historical background, main physiological mechanisms, and the most frequently used AAS substances. Second, data on the prevalence of AAS-induced male infertility and sexual dysfunction are described. Third, some new insights on possible underpinning mechanisms of AAS-induced male infertility and sexual dysfunction are thoroughly discussed, with particular attention to histological data derived from animal models and the latest insights from prospective cohorts in humans. Fourth, the potential treatments during and after the AAS usage are presented, highlighting the odds of resolving male infertility and sexual dysfunction. Fifth, future directions on this topic are discussed, focusing on the methodological robustness of scientific studies.

Keywords: AAS; anabolic androgenic steroids; andrology; performance enhancement; semen; spermatozoa; testis; testosterone.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Abrahin O. S. C., de Sousa E. C., Santos A. M. (2014). Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review. Subst. Use Misuse 49 (9), 1156–1162. 10.3109/10826084.2014.903750 - DOI - PubMed
    1. Agarwal A., Mulgund A., Hamada A., Chyatte M. R. (2015). A unique view on male infertility around the globe. Reproductive Biol. Endocrinol. 13 (1), 37. 10.1186/s12958-015-0032-1 - DOI - PMC - PubMed
    1. Al Hashimi M. (2022). The deleterious effects of anabolic androgenic steroid abuse on sexual and reproductive health and comparison of recovery between treated and untreated patients: single‐center prospective randomized study. Andrologia 54 (11), e14576. 10.1111/and.14576 - DOI - PMC - PubMed
    1. Anawalt B. D. (2019). Diagnosis and management of anabolic androgenic steroid use. J. Clin. Endocrinol. Metabolism 104 (7), 2490–2500. 10.1210/jc.2018-01882 - DOI - PMC - PubMed
    1. Athayde K. S., Cocuzza M., Agarwal A., Krajcir N., Lucon A. M., Srougi M., et al. (2007). Development of normal reference values for seminal reactive oxygen species and their correlation with leukocytes and semen parameters in a fertile population. J. Androl. 28 (4), 613–620. 10.2164/jandrol.106.001966 - DOI - PubMed

LinkOut - more resources